Skip to main content
Psychedex

1Provenance card

the boundary, as counts

Sources

3331 with DOI

26 strong · 6 moderate · 1 weak

Compilations

0no compilation run

16 other runs

Decisions

75last ruled 2026-10-03

32 awaiting a ruling

Issued documents

102026-10-19T20:32:32.507Z

notice · info card · emergency

Searches

00 with no results

queries and counts on the build

Claims checked

10274 supported

74 supported · 28 not

Correspondence

0received

consent field ships in Phase 4

Edges

341

derivations recorded for this entity

Complete over 33 sources and 75 decisions.Not here: the private journal (never); 32 proposals awaiting a ruling (listed as pending only).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/lsd/archive

Timeline

what happened, newest first — claims, searches and artifacts stay inside Build

  1. 2026-10-19issueIssued emergency
  2. 2026-10-19issueIssued info_card
  3. 2026-10-03revisionr1.a7
  4. 2026-10-03issueIssued info_card
  5. 2026-10-03srcPharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants
  6. 2026-10-03srcAcute Effects and Pharmacokinetics of LSD after Paroxetine or Placebo Pre-Administration in a Randomized, Double-Blind, Cross-Over Phase I Trial
  7. 2026-10-03srcAbsolute Oral Bioavailability and Bioequivalence of LSD Base and Tartrate in a Double-Blind, Placebo-Controlled, Crossover Study
  8. 2026-10-03srcA Review of Hallucinogen Persisting Perception Disorder (HPPD) and an Exploratory Study of Subjects Claiming Symptoms of HPPD
  9. 2026-10-03srcSafety pharmacology of acute LSD administration in healthy subjects
  10. 2026-10-03srcFlashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants
  11. 2026-10-03srcPharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects
  12. 2026-10-03srcAcute Effects of Lysergic Acid Diethylamide in Healthy Subjects
  13. 2026-10-03srcLysergic Acid Diethylamide-Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study
  14. 2026-10-03srcCrystal Structure of an LSD-Bound Human Serotonin Receptor
  15. 2026-10-03srcStructure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor
  16. 2026-10-03srcPsychedelics Promote Structural and Functional Neural Plasticity
  17. 2026-10-03srcIncreased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution
  18. 2026-10-03srcLSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a Phase 2a trial
  19. 2026-10-03srcReconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies
  20. 2026-10-03srcAcute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
  21. 2026-10-03srcDirect comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects
  22. 2026-10-03srcComparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants
  23. 2026-10-03srcPharmacological and non-pharmacological predictors of the LSD experience in healthy participants
  24. 2026-10-03srcPsychedelics promote plasticity by directly binding to BDNF receptor TrkB
  25. 2026-10-03srcGenetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis
  26. 2026-10-03srcNeural correlates of the LSD experience revealed by multimodal neuroimaging
  27. 2026-10-03srcPharmacological Treatment of Hallucinogen Persisting Perception Disorder (HPPD): A Systematic Review
  28. 2026-10-03srcChemistry/structural biology of psychedelic drugs and their receptor(s)
  29. 2026-10-03srcPsychedelics
  30. 2026-10-03srcLysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials
  31. 2026-10-03srcA low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers
  32. 2026-10-03srcMicrodosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins
  33. 2026-10-03srcLSD-assisted therapy in patients with anxiety: open-label prospective 12-month follow-up
  34. 2026-10-03srcThe entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs
  35. 2026-10-03srcHallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives
  36. 2026-10-03srcNew-Onset Seizures in an Adolescent Following Use of LSD while on Low-Dose Lithium Therapy: A Case Study
  37. 2026-10-03srcClassic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reports
  38. 2026-10-03publicationPublication — publishagent-psx
  39. 2026-10-03revisionr1.a6
  40. 2026-09-28runbrief run
  41. 2026-09-27runbrief run
  42. 2026-09-27runbrief run
  43. 2026-09-27runbrief run
  44. 2026-09-27runbrief run
  45. 2026-09-27runbrief run
  46. 2026-09-27revisionr1.a5
  47. 2026-09-24issueIssued info_card
  48. 2026-09-24publicationPublication — publishagent-psx (local dev)
  49. 2026-09-23runbrief run
  50. 2026-09-23revisionr1.a4
  51. 2026-09-23issueIssued info_card
  52. 2026-09-23issueIssued notice
  53. 2026-09-23publicationPublication — publishChris
  54. 2026-09-22runbrief run
  55. 2026-09-22runbrief run
  56. 2026-09-22revisionr1.a3
  57. 2026-09-20issueIssued info_card
  58. 2026-09-20publicationPublication — publishagent-psx (local dev)
  59. 2026-09-20revisionr1.a2
  60. 2026-09-18runbrief run
  61. 2026-09-18runbrief run
  62. 2026-09-18runbrief run
  63. 2026-09-04issueIssued emergency
  64. 2026-09-04issueIssued info_card
  65. 2026-09-04issueIssued notice
  66. 2026-08-24revisionr1.a1
  67. 2026-08-20proposalsafety_finding · toxicity · cardiovascular
  68. 2026-08-20proposalsafety_finding · toxicity · neurological
  69. 2026-08-20proposalsafety_finding · toxicity · reproductive
  70. 2026-08-20proposalsafety_finding · toxicity · serotonergic
  71. 2026-08-20proposalsafety_finding · toxicity · serotonergic
  72. 2026-08-20proposalsafety_finding · oral · toxicity · study_safety
  73. 2026-08-20proposalsafety_finding · oral · toxicity · serotonergic
  74. 2026-08-20proposalsafety_finding · toxicity · serotonergic
  75. 2026-08-20proposalsafety_finding · toxicity · neurological
  76. 2026-08-20proposalsafety_finding · toxicity · neurological
  77. 2026-08-20proposalsafety_finding · toxicity · neurological
  78. 2026-08-20proposalsafety_finding · toxicity · neurological
  79. 2026-08-20proposalsafety_finding · toxicity · serotonergic
  80. 2026-08-20proposalsafety_finding · toxicity · serotonergic
  81. 2026-08-20proposalsafety_finding · psychological_risks · psychosis
  82. 2026-08-20proposalsafety_finding · psychological_risks · psychosis
  83. 2026-08-20proposalsafety_finding · psychological_risks · psychosis
  84. 2026-08-20proposalsafety_finding · psychological_risks · hppd
  85. 2026-08-20proposalsafety_finding · psychological_risks · hppd
  86. 2026-08-20proposalsafety_finding · psychological_risks · hppd
  87. 2026-08-20proposalsafety_finding · psychological_risks · hppd
  88. 2026-08-20proposalsafety_finding · psychological_risks · hppd
  89. 2026-08-20proposalsafety_finding · toxicity · study_safety
  90. 2026-08-20proposalsafety_finding · toxicity · study_safety
  91. 2026-08-20proposalsafety_finding · toxicity · cardiovascular
  92. 2026-08-20proposalsafety_finding · toxicity · receptor_concern
  93. 2026-08-20proposalsafety_finding · toxicity · cardiovascular
  94. 2026-08-20proposalsafety_finding · toxicity · cardiovascular
  95. 2026-08-20proposalsafety_finding · toxicity · acute_toxicity
  96. 2026-08-20proposalsafety_finding · toxicity · adulterant_hazard
  97. 2026-08-20proposalsafety_finding · toxicity · mortality_record
  98. 2026-08-20proposalsafety_finding · oral · toxicity · safety_margin
  99. 2026-08-20runfindings run
  100. 2026-08-19runfindings run
  101. 2026-08-19runfindings run
  102. 2026-08-19runfindings run
  103. 2026-06-04proposal30 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
  104. 2026-06-04publicationPublication — backfill
  105. 2026-04-19revisionRevision 1

The same entries, as forms: six forms.